Overall, this study reports for the first time the role of ALDH5A1 in reshaping the metabolic scenario of GBM cells, and suggests that miR-210 mediated downregulation of ALDH5A1 might help GBM cells to maintain a high glycolytic phenotype. This evidence concerns the gene ALDH5A1 and glioblastoma.